Enhanced generation of interleukins 1β and 6 may contribute to the cachexia of chronic disease

American Journal of Clinical Nutrition

Volumn 65, Issue 3, 1997, Pages 876-882

  Cederholm, Tommy ^a   Wretlind, Bengt ^b   Hellström, Kjell ^b   Andersson, Birger ^b   Engström, Lennart ^b   Brismar, Kerstin ^b   Scheynius, Annika ^b   Forslid, Jan ^b   Palmblad, Jan ^b  

^a STOCKHOLM SÖDER HOSPITAL   (Sweden)

^b NONE

Author keywords

cachexia; Chronic disease; inflammation; insulin like growth factor 1; interleukin 1 receptor antagonist; interleukin 10; interleukin 1 ; interleukin 6; protein energy malnutrition; transforming growth factor 1; tumor necrosis factor

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

AGED; ARTICLE; BODY MASS; CACHEXIA; CLINICAL ARTICLE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; ELDERLY CARE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; IMMUNOPATHOLOGY; MALE; PATHOPHYSIOLOGY; PROTEIN CALORIE MALNUTRITION;

EID: 0031047629     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/65.3.876     Document Type: Article

References (48)

1. Barch DH, Fox CC, Mobarhan SA. Effects of chronic disease on nutrition. Nutr Int 1987;3:79-86.
2. Cederholm T, Jägrén C, Hellström K. Outcome of protein-energy malnutrition in elderly medical patients. Am J Med 1994;98:67-74.
3. Dowton SB, Colten HR. Acute phase reactants in inflammation and infection. Semin Hematol 1988;25:84-90.
4. Tracey KJ. TNF and other cytokines in the metabolism of septic shock and cachexia. Clin Nutr 1992;11:1-11.
5. Cederholm TE, Berg A, Johansson E, Hellström K, Palmblad J. Low levels of essential fatty acids are related to impaired delayed skin hypersensitivity in chronically ill elderly. Eur J Clin Invest 1994;24:615-20.
6. WHO, Joint FAO/WHO/UNU Expert Consultation Report. Energy and protein requirements. World Health Organ Tech Rep Ser 1985;724.
7. Symreng T. Arm anthropometry in a large reference population and in surgical patients. Clin Nutr 1983;1:211-9.
8. Symreng T, Groth O, Norr A, Schildt B, Zetterqvist H. Delayed hypersensitivity-critical evaluation of five recall antigens in a large reference population. Clin Nutr 1983;1:265-73.
9. Bang P, Eriksson U, Sara V, Wivall I-L, Hall K. Comparison of acid ethanol extraction and acid gel filtration prior to IGF-I and IGF-II radioimmunoassays: improvement of determinations in acid ethanol extracts by the use of truncated IGF-I as radioligand. Acta Endocrinol (Copenh) 1991;124:620-9.
10. Henter J-I, Blinder G, Söder O, Hansson M, Andersson B, Andersson U. Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood 1991;78:2918-22.
11. Forslid J, Heigl Z, Jonsson J, Scheynius A. The prevalence of antinuclear antibodies in healthy young persons and adults, comparing rat liver tissue sections with Hep-2 cells as antigen substrate. Clin Exp Rheumatol 1994;12:137-41.
12. Lipschitz DA, Mitchell CO. The correctability of the nutritional, immune and hematopoetic manifestations of protein calorie malnutrition in the elderly. J Am Coll Nutr 1982;1: 17-25.
13. Deitch EA, Winterton J, Li M, Berg R. The gut as a portal entry for bacteremia. Role of protein malnutrition. Ann Surg 1987;205:681-92.
14. Tracey KJ, Wei H, Manogue KR, et al. Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation. J Exp Med 1988;167:1211-27.
15. Moldawer LL, Andersson C, Gelin J, Lundholm KG. Regulation of food intake and hepatic protein synthesis by recombinant-derived cytokines. Am J Physiol 1988;254:G450-6.
16. Strassman D, Fong M, Windsor S, Neta R. The role of interleukin-6 in lipopolysaccharide-induced weight loss, hypoglycemia and fibrinogen production, in vivo. Cytokine 1993;5:285-90.
17. Sherry BA, Gelin J, Fong Y, et al. Anticachectin/tumor necrosis factor-α antibodies attenuate development of cachexia in tumor models. FASEB J 1989;3:1956-62.
18. Beutler B, Greenwald D, Hulmes JD, et al. Identity of tumour necrosis factor and the macrophage-secreted factor cachectin. Nature 1985; 316:552-4.
19. Fong Y, Moldawer LL, Marano M, et al. Cachectin/TNF or IL-1α induces cachexia with redistribution of body proteins. Am J Physiol 1989;256:R659-65.
20. Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute phase response. Biochem J 1990;265:621-36.
21. Tocco-Bradley R, Georgieff M, Jones CT, et al. Changes in energy expenditure and fat metabolism in rats infused with interleukin-1. Eur J Clin Invest 1987;17:504-10.
22. Le vine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990;323:236-41.
23. McMurray J, Abdullah I, Dargie HJ, Shairo D. Increased concentra lions of tumour necrosis factor in "cachectic" patients with severe chronic heart failure. Br Heart J 1991;66:356-8.
24. di Francia M, Barbier D, Mege JL, Orehek J. Tumor necrosis factor-α levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994;150:1453-5.
25. Sridhar MK. Why do patients with emphysema lose weight? Lancet 1995;345:1190-1.
26. Roubenoff R, Roubenoff RA, Cannon JG, et al. Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying body cell mass in chronic inflammation. J Clin Invest 1994;93:2379-86.
27. Keenan RA, Moldawer LL, Yang RD, Kawamura I, Blackburn GL, Bistrian BR. An altered response by peripheral leukocytes to synthesize or release leukocyte endogenous mediator in critically ill, protein-malnourished patients. J Lab Clin Med 1982;100:844-57.
28. Kauffman CA, Jones PG, Kluger MJ. Fever and malnutrition: endogenous pyrogen/interleukin-1 in malnourished patients. Am J Clin Nutr 1986;44:449-52.
29. Bradley SF, Vibhagool A, Fabrick S, Terpenning MS, Kauffman CA. Monokine production by malnourished nursing home patients. Gerontology 1990;36:165-70.
30. Bhaskaram P, Sivakumar B. Interleukin-1 in malnutrition. Arch Dis Child 1986;61:182-5.
31. Cederholm TE, Hellström K. Reversibility of protein-energy malnutrition in a group of chronically-ill elderly outpatients. Clin Nutr 1995;14:81-7.
32. Minute F, Barreca A, Adami GF, et al. Insulin-like growth factor-1 in human malnutrition: relationship with some body composition and nutritional parameters. JPEN J Parenter Enterai Nutr 1989;13:392-6.
33. Lazarus DD, Moldawer LL, Lowry SF. Insulin-like growth factor-1 activity is inhibited by interleukin-1α, tumor necrosis factor-α, and interleukin-6. Lymphokine Cytokine Res 1993;12:219-23.
34. Van Snick J. Interleukin-6: an overview. Annu Rev Immunol 1990;8:253-78.
35. Oka Y, Murata A, Nishijima J, et al. Circulating interleukin 6 as a useful marker for predicting postoperative complications. Cytokine 1992;4:298-304.
36. Nijsten MWN. de Groot ER, ten Duis HJ, Klasen HJ, Hack CE, Aarden LA. Serum levels of interleukin-6 and acute phase responses. Lancet 1987;2:921 (letter).
37. Casey LC, Balk RA, Bone RC. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 1993;119:771-8.
38. Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood 1991;77:1627-52.
39. Suzuki H, Takemura H, Kashiwagi H. Interleukin-1 receptor antagonist in patients with active systemic lupus erythematosus. Arthritis Rheum 1995;38:1055-9.
40. Gush JJ, Splawski JB, Thomas R, et al. Elevated interleukin-10 levels in patients with rheumatoid arthritis. Arthritis Rheum 1995;38:96-104.
41. Roberts AB, Anzano MA, Wakefield LM, et al. Type β transforming growth factor: a bifunctional regulator of cellular growth. Proc Natl Acad Sci U S A 1985;82:119-23.
42. Wang P, Wu P, Siegel MI, Egan RW, Billah MM. IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. J Immunol 1994;153:811-6.
43. Cassatella MA, Meda L, Bonora S, Ceska M, Constantin G. Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1β in mediating the production of IL-8 triggered by lipopolysaccharide. J Exp Med 1993;178:2207-11.
44. Bogdan C, Vodovotz Y, Hathan C. Macrophage deactivation by interleukin 10. J Exp Med 1991;174:1549-55.
45. Chandra RK. Nutritional regulation of immunity and risk of infection in old age. Immunology 1989;67:141-7.
46. Tomkins AM. Protein-energy malnutrition and risk of infection. Proc Nutr Soc 1986;45:289-304.
47. Beisel WR. Effects of infection on nutritional status and immunity. Fed Proc 1980;39:3105-8.
48. Sullivan DH, Walls RC, Lipschitz DA. Protein-energy undernutrition and the risk of mortality within 1 y of hospital discharge in a select population of geriatric rehabilitation patients. Am J Clin Nutr 1991; 53:599-605.